Education
About Us
Working with TipRanks
Follow Us
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
NATHBIOGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹141.10 - ₹254.25
Previous CloseN/A
Volume20.69K
Average Volume (3M)5.70K
Market Cap
₹4.29B
Enterprise Value₹3.36B
Total Cash (Recent Filing)₹888.99M
Total Debt (Recent Filing)₹1.23B
Price to Earnings (P/E)10.4
Beta1.20
Next Earnings
Oct 15, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 09, 2024Dividend Yield0.89%
Share Statistics
EPS (TTM)18.53
Shares Outstanding19,004,000
10 Day Avg. Volume8,218
30 Day Avg. Volume5,699
Financial Highlights & Ratios
PEG Ratio1.75
Price to Book (P/B)1.77
Price to Sales (P/S)0.00
P/FCF Ratio-20.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nath Bio-Genes (India) Ltd. News
PremiumCompany Announcements
Nath Bio-Genes Releases Q3 FY25 Financial Results
PremiumCompany Announcements
Nath Bio-Genes Submits Compliance Certificate for Q4 2024NATHBIOGEN FAQ
What was Nath Bio-Genes (India) Ltd.’s price range in the past 12 months?
Nath Bio-Genes (India) Ltd. lowest stock price was ₹141.10 and its highest was ₹254.25 in the past 12 months.
What is Nath Bio-Genes (India) Ltd.’s market cap?
Nath Bio-Genes (India) Ltd.’s market cap is ₹4.29B.
When is Nath Bio-Genes (India) Ltd.’s upcoming earnings report date?
Nath Bio-Genes (India) Ltd.’s upcoming earnings report date is Oct 15, 2025 which is in 92 days.
How were Nath Bio-Genes (India) Ltd.’s earnings last quarter?
Nath Bio-Genes (India) Ltd. released its earnings results on Jul 11, 2025. The company reported ₹18.532 earnings per share for the quarter, beating the consensus estimate of N/A by ₹18.532.
Is Nath Bio-Genes (India) Ltd. overvalued?
According to Wall Street analysts Nath Bio-Genes (India) Ltd.’s price is currently Overvalued.
Does Nath Bio-Genes (India) Ltd. pay dividends?
Nath Bio-Genes (India) Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 0.89%. See more information on Nath Bio-Genes (India) Ltd. dividends here
What is Nath Bio-Genes (India) Ltd.’s EPS estimate?
Nath Bio-Genes (India) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nath Bio-Genes (India) Ltd. have?
Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding.
What happened to Nath Bio-Genes (India) Ltd.’s price movement after its last earnings report?
Nath Bio-Genes (India) Ltd. reported an EPS of ₹18.532 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.375%.
Which hedge fund is a major shareholder of Nath Bio-Genes (India) Ltd.?
Currently, no hedge funds are holding shares in IN:NATHBIOGEN
Company Description
Nath Bio-Genes (India) Ltd.
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.
Technical Analysis
Aries Agro Ltd.
―
Continental Seeds & Chemicals Ltd.
―
Goodricke Group Ltd
―
Harrisons Malayalam Ltd
―
Nova Agritech Limited
―